These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6170430)

  • 1. Chemotherapeutic trials with hamster mesothelioma 10-24: responses to azacitidine, aziridinylbenzoquinone, cisplatin, and PCNU.
    Holiat SM; Smith WE; Hubert DD; Davis S
    Cancer Treat Rep; 1981; 65(11-12):1113-5. PubMed ID: 6170430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete remissions in chemotherapy of lung cancer models induced in mice by asbestos.
    Smith WE; Hubert DD; Yazdi E; Holiat SM; Bissell EC; Watts LM; Baylouny RA; Sobel HJ
    Mt Sinai J Med; 2005 Jan; 72(1):23-32. PubMed ID: 15682259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum.
    Schold SC; Rawlings CE; Bigner SH; Bigner DD
    Neurosurgery; 1983 Jun; 12(6):672-7. PubMed ID: 6683794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of aziridinylbenzoquinone administered Iv to beagle dogs.
    Hacker MP; Hong CB; McKee MJ; Unwin SE; Urbanek MA
    Cancer Treat Rep; 1982 Oct; 66(10):1845-51. PubMed ID: 7127322
    [No Abstract]   [Full Text] [Related]  

  • 5. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
    Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ
    Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of aziridinylbenzoquinone in refractory lymphoma.
    Case DC; Hayes DM
    Cancer Treat Rep; 1983 Nov; 67(11):993-6. PubMed ID: 6357437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Tan CT; Hancock CH; Mondora A; Hoffman NW
    Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.
    Da Silva VF; Raaphorst GP; Goyal R; Feeley M
    J Neurosurg; 1987 Dec; 67(6):885-8. PubMed ID: 3681426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.
    Creagan ET; Schutt AJ; Ahmann DL; Green SJ
    Cancer Treat Rep; 1982 Dec; 66(12):2089-90. PubMed ID: 7139650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of diaziquone in malignant mesothelioma.
    Eagan RT; Frytak S; Richardson RL; Creagan ET; Nichols WC
    Cancer Treat Rep; 1986 Mar; 70(3):429. PubMed ID: 3955559
    [No Abstract]   [Full Text] [Related]  

  • 11. AZQ therapy in patients with disseminated malignant melanoma.
    Yap BS; Bedikian AY; Burgess MA; Bodey GP
    Am J Clin Oncol; 1982 Dec; 5(6):623-5. PubMed ID: 7165003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
    Tannock I
    Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.
    Johnson RK; Wodinsky I; Swiniarski J; Meaney KF; Clement JJ
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1605-9. PubMed ID: 583418
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase I trial of aziridinylbenzoquinone (NSC 192986) in patients with previously treated acute leukemia.
    Van Echo DA; Schulman P; Budman DR; Ferrari A; Wiernik PH
    Am J Clin Oncol; 1982 Aug; 5(4):405-10. PubMed ID: 7113963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental combination chemotherapy: intracarotid versus intravenous administration of aziridinylbenzoquinone, BCNU, and cisplatin in dogs.
    Wright KC; Stephens LC; Wallace S; Savaraj N; Feun LG
    Chemotherapy; 1987; 33(6):437-44. PubMed ID: 3428010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I evaluation and pharmacokinetics of aziridinylbenzoquinone using a weekly intravenous schedule.
    Schilcher RB; Young JD; Leichman LP; Haas CD; Baker LH
    Cancer Res; 1983 Aug; 43(8):3907-11. PubMed ID: 6683127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II clinical evaluation of AZQ in colorectal cancer.
    Bedikian AY; Stroehlein JR; Karlin DA; Korinek J; Bodey GP
    Am J Clin Oncol; 1982 Oct; 5(5):535-7. PubMed ID: 7180831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
    Budman DR; Forastiere A; Perloff M; Perry M; Aisner J; Weinberg V; Wood W
    Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma.
    Chahinian AP; Norton L; Holland JF; Szrajer L; Hart RD
    Cancer Res; 1984 Apr; 44(4):1688-92. PubMed ID: 6423278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
    Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
    Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.